Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001749475-19-000001
Filing Date
2019-10-10
Accepted
2019-10-10 09:22:38
Documents
1
Effectiveness Date
2019-10-10
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7786
  Complete submission text file 0001749475-19-000001.txt   9011
Mailing Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP PLATINUM HOUSE, 21 HA'ARBA'AH ST. TEL AVIV L3 64739
Business Address SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP PLATINUM HOUSE, 21 HA'ARBA'AH ST. TEL AVIV L3 64739 972-3-6845535
Sphera Biotech US Fund, L.P. (Filer) CIK: 0001749475 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-323124 | Film No.: 191145415